537253 — Sunil Healthcare Income Statement
0.000.00%
- IN₹830.63m
- IN₹1.48bn
- IN₹834.21m
- 38
- 39
- 67
- 46
Annual income statement for Sunil Healthcare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 903 | 1,192 | 1,105 | 902 | 834 |
Cost of Revenue | |||||
Gross Profit | 476 | 707 | 633 | 438 | 468 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 911 | 1,081 | 1,013 | 920 | 795 |
Operating Profit | -7.63 | 111 | 91.5 | -18.3 | 39.1 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -5.53 | 92.6 | 94.8 | -25.6 | -12.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | -6.38 | 64.2 | 66.8 | -17.8 | -14.2 |
Net Income Before Extraordinary Items | |||||
Net Income | -6.38 | 64.2 | 66.8 | -17.8 | -14.2 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -6.38 | 64.2 | 66.8 | -17.9 | -14.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.584 | 6.26 | 6.45 | -1.63 | -1.38 |